US equities |
MU $896.07 ▼-0.98% SPCX $147.79 ▼-0.11% NVDA $216.47 ▼-0.29% AAPL $339.50 ▼-1.00% TSLA $373.71 ▲+1.54% META $694.25 ▼-1.59% AMZN $262.63 ▲+0.07% SNDK $1,365.38 ▼-0.42%
FinancialContent

Articles published by Hepion Pharmaceuticals

News headline image
Hepion Pharmaceuticals Receives Positive FDA Response on GV104 in Gambling Disorder, a Condition With No Approved Medication
From Hepion Pharmaceuticals
Via ACCESS Newswire
Tickers HEPA
News headline image
Hepion Pharmaceuticals Completes Acquisition of Gravitas Life Sciences and Provides Corporate Update
From Hepion Pharmaceuticals
Via ACCESS Newswire
Tickers HEPA